Parathyroid hormone, cardiovascular and all-cause mortality: A meta-analysis

Clinica Chimica Acta

Volumn 455, Issue , 2016, Pages 154-160

  Yang, Bo ^a   Lu, Changlin ^b   Wu, Qing ^a   Zhang, Jian ^a   Zhao, Hua ^a   Cao, Yukang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

All cause mortality; Cardiovascular mortality; Meta analysis; Parathyroid hormone

Indexed keywords

PARATHYROID HORMONE;

ALL CAUSE MORTALITY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; DISEASE ASSOCIATION; HUMAN; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEX DIFFERENCE; CARDIOVASCULAR DISEASE; META ANALYSIS; METABOLISM;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HUMANS; PARATHYROID HORMONE;

EID: 84958551611     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.01.034     Document Type: Review

References (40)

1. Perk J., De Backer G., Gohlke H., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 2012, 223:1-68.
2. Fraser W.D. Hyperparathyroidism. Lancet 2009, 374:145-158.
3. Bhuriya R., Li S., Chen S.C., McCullough P.A., Bakris G.L. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Am. J. Kidney Dis. 2009, 53:S3-10.
4. Koizumi M., Komaba H., Fukagawa M. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Contrib. Nephrol. 2013, 180:110-123.
5. Tomaschitz A., Ritz E., Pieske B., et al. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism 2014, 63:20-31.
6. Fitzpatrick L.A., Bilezikian J.P., Silverberg S.J. Parathyroid hormone and the cardiovascular system. Curr. Osteoporos. Rep. 2008, 6:77-83.
7. Hagstrom E., Hellman P., Larsson T.E., et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009, 119:2765-2771.
8. Anderson J.L., Vanwoerkom R.C., Horne B.D., et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?. Am. Heart J. 2011, 162:331-339. e332.
9. Bjorkman M.P., Sorva A.J., Tilvis R.S. Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. Eur. J. Endocrinol. 2008, 158:749-753.
10. Kritchevsky S.B., Tooze J.A., Neiberg R.H., et al. 25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults: the health ABC study. J. Clin. Endocrinol. Metab. 2012, 97:4156-4165.
11. van Ballegooijen A.J., Reinders I., Visser M., et al. Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study. J. Clin. Endocrinol. Metab. 2013, 98:E638-E645.
12. Szulc P., Claustrat B., Delmas P.D. Serum concentrations of 17beta-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men-the MINOS study. Clin. Endocrinol. 2009, 71:594-602.
13. Cawthon P.M., Parimi N., Barrett-Connor E., et al. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J. Clin. Endocrinol. Metab. 2010, 95:4625-4634.
14. Kestenbaum B., Katz R., de Boer I., et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J. Am. Coll. Cardiol. 2011, 58:1433-1441.
15. Lee D.M., Vanderschueren D., Boonen S., et al. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men. Age Ageing 2014, 43:528-535.
16. Folsom A.R., Alonso A., Misialek J.R., et al. Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study. Am. Heart J. 2014, 168:296-302.
17. Palmer S.C., Hayen A., Macaskill P., et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011, 305:1119-1127.
18. van Ballegooijen A.J., Reinders I., Visser M., Brouwer I.A. Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies. Am. Heart J. 2013, 165:655-664. (664 e651-655).
19. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
20. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
21. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
22. Pilz S., Tomaschitz A., Drechsler C., et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur. Heart J. 2010, 31:1591-1598.
23. Grandi N.C., Breitling L.P., Hahmann H., et al. Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease. Heart 2011, 97:1215-1221.
24. Natoli J.L., Boer R., Nathanson B.H., et al. Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis. BMC Nephrol. 2013, 14:88.
25. Jassal S.K., Chonchol M., von Muhlen D., Smits G., Barrett-Connor E. Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. Am. J. Med. 2010, 123:1114-1120.
26. Tastan I., Schreckenberg R., Mufti S., Abdallah Y., Piper H.M., Schluter K.D. Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way. Cardiovasc. Res. 2009, 82:77-83.
27. Saleh F.N., Schirmer H., Sundsfjord J., Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur. Heart J. 2003, 24:2054-2060.
28. van Ballegooijen A.J., Visser M., Kestenbaum B., et al. Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study). Am. J. Cardiol. 2013, 111:418-424.
29. Pirro M., Manfredelli M.R., Helou R.S., et al. Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J. Atheroscler. Thromb. 2012, 19:924-931.
30. Bosworth C., Sachs M.C., Duprez D., et al. Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clin. Endocrinol. 2013, 79:429-436.
31. Taylor E.N., Curhan G.C., Forman J.P. Parathyroid hormone and the risk of incident hypertension. J. Hypertens. 2008, 26:1390-1394.
32. van Ballegooijen A.J., Kestenbaum B., Sachs M.C., et al. Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 2014, 63:1214-1222.
33. Lee D.M., Rutter M.K., O'Neill T.W., et al. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur. J. Endocrinol. 2009, 161:947-954.
34. Chiu K.C., Chuang L.M., Lee N.P., et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 2000, 49:1501-1505.
35. Alemzadeh R., Kichler J. Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents. Metab. Syndr. Relat. Disord. 2012, 10:422-429.
36. Guasch A., Bullo M., Rabassa A., et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc. Diabetol. 2012, 11:149.
37. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur. J. Cardiovasc. Prev. Rehabil. 2004, 11:69-74.
38. Taylor E.N., Rimm E.B., Stampfer M.J., Curhan G.C. Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am. Heart J. 2011, 161:956-962.
39. Hagstrom E., Ingelsson E., Sundstrom J., et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur. J. Heart Fail. 2010, 12:1186-1192.
40. Altay H., Zorlu A., Binici S., et al. Relation of serum parathyroid hormone level to severity of heart failure. Am. J. Cardiol. 2012, 109:252-256.